Molecular Formula | C60H90N6O14
|
Molar Mass | 1119.39 |
Density | 1.104±0.06 g/cm3(Predicted) |
Boling Point | 1219.3±65.0 °C(Predicted) |
Solubility | DMSO: 31 mg/mL (27.69 mM)( < 1 mg/ml refers to the product slightly soluble or insoluble) |
pKa | 5.34±0.40(Predicted) |
Storage Condition | 2-8°C |
Use | Emodepside (PF 1022-221) is a cyclic heptatriene peptide with broad-spectrum anthelmintic activity. |
Target | Parasite |
In vitro study | Emodepside is a semisynthetic derivative of PF1022A, which contains a morpholine attached in para position at each of both D-phenyllactic acids. Emodepside is efficacious against a variety of gastrointestinal nematodes. Emodepside binds to a presynaptic latrophilin receptor in nematodes. Emodepside produces a slow time-dependent (20 min), 4-aminopyridine sensitive, concentration-dependent hyperpolarization and increase in voltage-activated K currents. Emodepside has an inhibitory effect on spiking. Emodepside significantly inhibits the ryanodine increase in spike frequency between the 20 and 35 min period by 9.8 spikes/min. In the presence of emodepside, highly increased currents are observed without depolarization up to a threshold of 0 mV and without any additional stimuli to artificially increase [Ca 2+ ]i levels. These novel findings confirm that Slo-1 is a direct target of emodepside. |
In vivo study | Emodepside interferes with signaling at the neuromuscular junction on the body-wall muscles, pharynx and egg-laying muscles and thus inhibits three important physiological functions: locomotion, feeding and reproduction. |